Close X
Monday, November 25, 2024
ADVT 
International

US to start student visa application process from mid-May

Darpan News Desk IANS, 02 May, 2023 03:47 PM
  • US to start student visa application process from mid-May

New Delhi, May 2 (IANS) The US will begin processing student visa applications for the Fall Session with the first batch of appointments available from mid-May.

"Attention students! In mid-May, the US Mission to India will open the first batch of appointments for the upcoming student visa season," the US Consulate General in Hyderabad announced via a tweet.

"Additional appointments will be released later in the season. Prepare for your appointments and stay tuned for more student visa related announcements," it said.

The US consulates processed nearly 1.25 lakh visa applications of students in India last year.

The country intends to increase visa interview appointments for Indian students by 30 per cent this summer.

In a much needed breather for students, the State Department announced in February that the 'F' and 'M' categories of student visas can now be issued up to a year in advance.

Previously, international students could apply only 120 days before the start of their study program.

Now they can submit their application 365 days in advance.

The development comes with the State Department announcing a hike in the fees of student visas.

Beginning May 30, the fees for non-petition based NIVs such as student and exchange visitor visas, will increase from $160 to $185 (Rs 15,140 for Indians).

MORE International ARTICLES

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report